← All trials
NCT02622659
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2012
- Primary completion
- Mar 1, 2014
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 468
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Guangzhou Yipinhong Pharmaceutical CO.,LTDLead sponsor
- Changzhou traditional Chinese medicine hospitalOverall official - principal investigator
- Changzhi City People's HospitalOverall official - principal investigator
- Chongqing Medical UniversityOverall official - principal investigator
- Nanchang UniversityOverall official - principal investigator
- Central South UniversityOverall official - principal investigator
- Handan Traditional Chinese Medicine HospitalOverall official - principal investigator
- Guangxi Medical UniversityOverall official - principal investigator
- Luohe Hospital of Traditional Chinese MedicineOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.